- Home
- HAVA vs PALI Comparison
HAVA vs PALI Comparison
Compare HAVA & PALI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
N/A
Current Price
$1.23
Company Overview
Basic Information| Metric | HAVA | PALI |
|---|---|---|
| Founded | 2024 | 1996 |
| Country | South Korea | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 209.0M | 249.2M |
| IPO Year | 2025 | 2019 |
Fundamental Metrics
Financial Performance| Metric | HAVA | PALI |
|---|---|---|
| Price | $10.28 | $1.23 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 10 |
| Target Price | N/A | ★ $9.80 |
| AVG Volume (30 Days) | 115.8K | ★ 2.9M |
| Earning Date | 01-01-0001 | 11-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 97.06 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $260,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 1500.39 |
| 52 Week Low | $9.90 | $1.08 |
| 52 Week High | $10.30 | $2.86 |
Technical Indicators
Market Signals| Indicator | HAVA | PALI |
|---|---|---|
| Relative Strength Index (RSI) | 65.37 | 34.64 |
| Support Level | $9.98 | N/A |
| Resistance Level | N/A | $2.18 |
| Average True Range (ATR) | 0.00 | 0.10 |
| MACD | -0.00 | -0.01 |
| Stochastic Oscillator | 64.29 | 21.87 |
Price Performance
Historical Comparison HAVA
PALI
About HAVA Harvard Ave Acquisition Corporation Class A Ordinary Share
Harvard Ave Acquisition Corp is a blank check company.
About PALI Palisade Bio Inc.
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.